The parties agree to collaborate on research in genetics, regenerative and alternative medicine
As part of the LOI, the MGRC, which has a high-throughput sequencing lab, a state-of-the-art microarray facility and a new state-of-the-art cell processing lab, as well as Genotec, which specializes in biomedical treatments using stem cells, will help strengthen the teaching and research activities of the undergraduate program of the Faculty of Science and Natural Resources of UMS.
This cooperation will allow the exchange of resources and research ideas to improve the quality of research at UMS, as well as create opportunities for students of the Faculty of Science and Natural Resources to do their internship at the MGRC or at Genotec.
President of Malaysian Genomics, Datuk Seri Dr.
The signing of the Letter of Intent follows UMS’s visit to the MGRC’s Biosafety Level 2 cGMP (Current Good Manufacturing Practice) certified laboratory, which is used for the production of cell therapies, including cell therapies CAR T for various cancers.
(C) 2022 M2 COMMUNICATIONS, source